Variability of Values for the Atherogenic Index (ATH index) in Healthy Men
,
Abstract
No Abstract
1. Høstmark AT, Osland A, Simonsen S, Le-vorstad K (1990). Lipoprotein-related coronary risk factors in patients with an-giographically defined coronary artery disease: relation to number of stenosed arteries. J Intern Med, 228 (4): 317-21.
2. Berg JE, Høstmark AT (1994). Cardiovascu-lar risk determination: discrepancy be-tween total cholesterol evaluation and two compound laboratory indices in Norway. J Epidemiol Community Health, 48 (4): 338-43.
3. National Cholesterol Education Program (NCEP) (2002). Expert Panel on Detec-tion, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circula-tion, 106 (25): 3143-421.
4. Contois JH, McNamara JR, Lammi-Keefe CJ, et al (1996). Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immuno-turbidimetric assay: results from the Framingham Offspring Study. Clin Chem, 42 (4): 507-14.
5. Contois JH, McNamara JR, Lammi-Keefe CJ, et al (1996). Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbi-dimetric assay: results from the Framing-ham Offspring Study. Clin Chem, 42 (4): 515-23.
2. Berg JE, Høstmark AT (1994). Cardiovascu-lar risk determination: discrepancy be-tween total cholesterol evaluation and two compound laboratory indices in Norway. J Epidemiol Community Health, 48 (4): 338-43.
3. National Cholesterol Education Program (NCEP) (2002). Expert Panel on Detec-tion, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circula-tion, 106 (25): 3143-421.
4. Contois JH, McNamara JR, Lammi-Keefe CJ, et al (1996). Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immuno-turbidimetric assay: results from the Framingham Offspring Study. Clin Chem, 42 (4): 507-14.
5. Contois JH, McNamara JR, Lammi-Keefe CJ, et al (1996). Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbi-dimetric assay: results from the Framing-ham Offspring Study. Clin Chem, 42 (4): 515-23.
| Files | ||
| Issue | Vol 50 No 6 (2021) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v50i6.6431 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Kaneva A, Potolitsyna N, Bojko E. Variability of Values for the Atherogenic Index (ATH index) in Healthy Men. Iran J Public Health. 2021;50(6):1282-1284.
